Anna-Karin E. Palm
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
Papers in
- Immunology 12
- T-cell and B-cell Immunology 7
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 6
- Immune Response and Inflammation 4
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Carole Henry (5 shared papers)Patrick C. Wilson (5 shared papers)Florian Krammer (3 shared papers)Sandra Kleinau (4 shared papers)Karlynn E. Neu (3 shared papers)Min Huang (3 shared papers)Linda Yu-Ling Lan (2 shared papers)George Georgiou (1 shared paper)
- Journals
- Veterinary Immunology and Immunopathology (2 papers)Frontiers in Immunology (2 papers)Scientific Reports (2 papers)Journal of Virology (1 paper)Science Immunology (1 paper)
- Partner nations
- SwedenUnited States
In The Last Decade
Anna-Karin E. Palm
17 papers receiving 859 citations
Peers
Comparison fields: 5 of 82
- Immunology 448
- Infectious Diseases 237
- Epidemiology 295
- Modeling and Simulation 24
- Equine 8
Countries citing papers authored by Anna-Karin E. Palm
This map shows the geographic impact of Anna-Karin E. Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Karin E. Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Karin E. Palm more than expected).
Fields of papers citing papers by Anna-Karin E. Palm
This network shows the impact of papers produced by Anna-Karin E. Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Karin E. Palm. The network helps show where Anna-Karin E. Palm may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna-Karin E. Palm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 186 | |
| 2 | 2017 | 185 | |
| 3 | 2017 | 167 | |
| 4 | 2020 | 76 | |
| 5 | 2021 | 65 | |
| 6 | 2023 | 65 | |
| 7 | 2015 | 23 | |
| 8 | 2016 | 22 | |
| 9 | 2016 | 22 | |
| 10 | 2019 | 18 | |
| 11 | The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1. | 2001 | 15 |
| 12 | 2012 | 14 | |
| 13 | 2016 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 2 |
About Anna-Karin E. Palm
Anna-Karin E. Palm is a scholar working on Immunology, Infectious Diseases, Epidemiology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 17 papers that have together received 880 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (6 papers), Immune Response and Inflammation (4 papers), Influenza Virus Research Studies (3 papers), Diabetes and associated disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Immunology (448 citations), Infectious Diseases (237 citations), Epidemiology (295 citations), Modeling and Simulation (24 citations) and Equine (8 citations). Anna-Karin E. Palm has collaborated with scholars based in Sweden and United States. Frequent co-authors include Carole Henry, Patrick C. Wilson, Florian Krammer, Sandra Kleinau, Karlynn E. Neu, Min Huang, Linda Yu-Ling Lan, George Georgiou, Yunping Huang and Sarah F. Andrews. Their work appears in journals such as Veterinary Immunology and Immunopathology, Frontiers in Immunology, Scientific Reports, Journal of Virology and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.